Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Single-Arm Study to Investigate the Efficacy and Safety of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

NCT06859294 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT06859294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06859294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Single-Arm Study to Investigate the Efficacy and Safety of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
March 19, 2025
Completion date
June 5, 2026
Enrollment
35 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis